Arkolith/Insider Trading/ETON/Form 4/A

Opaleye Management Inc.

10% OwnerEton Pharmaceuticals, Inc. (ETON) · full profile →Form 4/A · filed Jul 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 14, 2026Sell(S)15K$37.54$563K2.7M
Jul 14, 2026Sell(S)13K$37.54$500K40K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001493152-26-033818) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML